Dogwood Therapeutics logo

Dogwood Therapeutics

DWTXXNAS

Dogwood Therapeutics is a pharmaceutical preparations company trading on XNAS, led by CEO Gregory Duncan, with a market cap of $101.7M.

CEOGregory Duncan
Market Cap$101.7M
PHARMACEUTICAL PREPARATIONS
Employees4.0
Websitevirios.com

Next Earnings

Upcoming earnings announcement for Dogwood Therapeutics

Date
Thursday, May 7, 2026 (in 3 months)
Timing
Before Market Open (9:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.49

Earnings History

Past 5 earnings reports for Dogwood Therapeutics

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Nov 6, 2025Q3 2025
-$8.20Est: -$1.44
-469.4%
-
SEC10-Q
Aug 13, 2025Q2 2025
-$1.99Est: -$1.25
-59.2%
-
SEC10-Q
May 8, 2025Q1 2025
-$8.45
-
SEC10-Q
Mar 31, 2025Q4 2024
-$6.29
-
SEC10-K
Nov 7, 2024Q3 2024
-$2.05
-
SEC10-Q

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

Dogwood Therapeutics (DWTX) Q1 2026 Earnings - Capbase